On the back of the CE Mark, Oncosil will now make applications with the TGA in Australia and regulators in New Zealand, Hong Kong and Singapore, the 27 EU Member States plus the UK and the 4 EFTA European countries and Switzerland and Turkey. Japan also recognises CE under mutual recognition. So, plenty of announcements should be coming out soon.
The CE Mark along with the breakthrough technology recognition by the EU and the FDA in the US should also facilitate greater partner or strategic alliances in these key jurisdictions. Make no mistake these are very exciting times for the Company and shareholders!
Ann: Oncosil breakthrough device receives CE Marking approval, page-83
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.00 |
Change
0.030(3.09%) |
Mkt cap ! $14.22M | |||
| Open | High | Low | Value | Volume |
| 99.5¢ | $1.00 | 96.0¢ | $39.65K | 40.44K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3000 | 96.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.01 | 391 | 2 |
View Market Depth
| Last trade - 16.10pm 24/06/2025 (20 minute delay) ? |
| OSL (ASX) Chart |